← back to search
Regan Rostorfer
University of Florida Health
· US
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Anastrozole, Medicine, Internal medicine, Oncology, and Fulvestrant.
h-index
—
citations
217
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer
Clinical Cancer Research
2019
cited by
217
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
—
·
1
papers (2019–2019)
Philip J. Ebert
· Eli Lilly (United States)
1
papers (2019–2019)
Chiun‐Sheng Huang
· National Taiwan University Hospital
1
papers (2019–2019)
—
·
1
papers (2019–2019)
Valentina Guarneri
· Mario Negri Institute for Pharmacological Research
1
papers (2019–2019)
David Chan
· The University of Sydney
1
papers (2019–2019)
—
·
1
papers (2019–2019)
Michael F. Press
· University of Southern California
1
papers (2019–2019)
Sara A. Hurvitz
· University of Washington Applied Physics Laboratory
1
papers (2019–2019)
Amit Aggarwal
· Daiichi Sankyo (United States)
1
papers (2019–2019)
Jiangang Liu
· Eli Lilly (United States)
1
papers (2019–2019)
—
·
1
papers (2019–2019)
—
·
1
papers (2019–2019)
Edgar Petru
· AGO Austria
1
papers (2019–2019)
Miguel Martín
· Spanish Ovarian Cancer Research Group
1
papers (2019–2019)
Anwar Hossain
· Apollo Hospitals
1
papers (2019–2019)
Dennis J. Slamon
· APLA Health
1
papers (2019–2019)
Susana Barriga
· Acacia Pharma (United Kingdom)
1
papers (2019–2019)